Insulin Lispro Shortage Update: What Patients Need to Know in 2026

Updated:

March 13, 2026

Author:

Peter Daggett

Summarize this blog with AI:

The latest on the Insulin Lispro shortage in 2026. Find out which formulations are affected, what the current pricing looks like, and how to find it in stock.

Insulin Lispro in 2026: Where Things Stand

If you rely on Insulin Lispro to manage your diabetes, you've probably felt the impact of supply disruptions over the past couple of years. The shortages that began in 2024 have evolved — some formulations are back in steady supply, while others remain hard to find.

This article gives you the latest on the Insulin Lispro shortage situation in 2026, including which products are affected, how pricing has changed, and what you can do right now to make sure you don't run out of your medication.

Is Insulin Lispro Still in Shortage?

The short answer: it depends on which formulation you use.

Here's the current picture:

  • 10 mL vials (100 units/mL): Generally available. The national supply of Insulin Lispro vials has largely stabilized, and most pharmacies can order them from their wholesalers.
  • KwikPen prefilled pens (100 units/mL): Mostly available, though specific pharmacies may experience intermittent stock-outs depending on their distributor.
  • 3 mL vials: Discontinued. Eli Lilly officially discontinued this presentation in October 2025. If you previously used the 3 mL vials, you'll need to switch to the 10 mL vial or a pen product.
  • 200 units/mL KwikPen: Generally available for patients prescribed the concentrated formulation.
  • Admelog (Sanofi): Sanofi has reported supply shortages for Insulin Lispro Sanofi (Admelog) affecting European markets starting in Q1 2026. U.S. supply of Admelog may also be affected intermittently.

The ASHP (American Society of Health-System Pharmacists) continues to track specific NDCs that are in limited supply. While the situation has improved significantly since the peak of the shortage in 2024, some patients — particularly in rural areas or those who use less common formulations — may still face challenges.

Why Has Insulin Lispro Been Hard to Find?

Several factors have contributed to the ongoing supply challenges:

The Price Cut Demand Surge

When Eli Lilly cut Humalog's list price by 70% in 2023 and lowered generic Insulin Lispro vials to $25, demand surged. More patients gained access to affordable insulin — a great development — but manufacturers needed time to scale up production to meet the new volume.

Manufacturing Transitions

Lilly's decision to discontinue the 3 mL vial presentations meant retooling production lines. These transitions don't happen overnight, and during the switchover, supply of certain products was reduced.

Global Supply Chain Factors

Insulin is a biologic product that requires specialized manufacturing facilities. Sanofi's reported shortages in Europe for their Insulin Lispro products suggest that global manufacturing capacity for rapid-acting insulin remains tight. This can create secondary effects on U.S. supply as manufacturers allocate limited capacity across markets.

For more background on why this medication has been difficult to locate, read our article on why Insulin Lispro is so hard to find.

How Much Does Insulin Lispro Cost in 2026?

The pricing landscape for Insulin Lispro has changed dramatically — mostly for the better. Here's what you can expect:

With Insurance

  • Medicare Part D: Copays are capped at $35 per month per insulin product under the Inflation Reduction Act
  • Commercial insurance: Many plans have followed suit with $35/month copay caps. Generic Insulin Lispro is typically on Tier 2 or Tier 3 of most formularies.
  • Lilly Insulin Value Program: Caps out-of-pocket cost at $35/month for all Lilly insulins, available to commercially insured and uninsured patients

Without Insurance

  • Generic Insulin Lispro vial (10 mL): As low as $25 at retail (Lilly's authorized generic)
  • Humalog vial: Approximately $100-$150 after Lilly's 70% price reduction
  • KwikPen 5-pack (generic): Approximately $175-$275 at retail; as low as $50-$80 with discount coupons

For detailed savings strategies, including coupons and patient assistance programs, see our complete guide on how to save money on Insulin Lispro in 2026.

New Options and Developments

Several developments in 2025 and 2026 have expanded options for patients who use rapid-acting insulin:

Biosimilar and Generic Expansion

The availability of generic and biosimilar Insulin Lispro products continues to expand. Multiple manufacturers now offer authorized generic versions, increasing overall supply and price competition.

Lyumjev Availability

Eli Lilly's Lyumjev (insulin lispro-aabc) — the ultra-rapid version of Insulin Lispro — is increasingly available and covered by the same Lilly Insulin Value Program at $35/month. Some patients have found Lyumjev easier to locate during periods when standard Insulin Lispro is in short supply.

Insulin Price Transparency

Tools like Medfinder make it easier than ever to compare pharmacy availability and find where your medication is in stock, reducing the guesswork that used to make shortages even more stressful.

How to Find Insulin Lispro in Stock

If you're currently struggling to find Insulin Lispro, here are the most effective steps:

  1. Search on Medfinder to find pharmacies near you with current stock
  2. Ask about all formulations — if the KwikPen is out, the vial may be available
  3. Check independent pharmacies — they often have better availability than large chains
  4. Consider mail-order pharmacies for a 90-day supply
  5. Ask your pharmacist to special-order from their wholesaler

For a complete guide with more strategies, read our article on how to find Insulin Lispro in stock near you.

What to Do If You Can't Find It

If Insulin Lispro simply isn't available in any form:

  • Contact your doctor about switching to an alternative rapid-acting insulin like Insulin Aspart (NovoLog), Insulin Glulisine (Apidra), or Afrezza
  • Never skip doses. Going without mealtime insulin can lead to dangerous hyperglycemia
  • Call Eli Lilly at 1-800-545-6962 for help locating supply or obtaining samples through your provider

Final Thoughts

The Insulin Lispro shortage situation in 2026 is better than it was in 2024, but it's not fully resolved. Certain formulations have been discontinued, global supply remains tight for some products, and regional variations in availability persist.

The best thing you can do is stay informed, plan ahead (try to refill before you're down to your last pen or vial), and use tools like Medfinder to stay on top of local pharmacy stock.

Check Insulin Lispro availability near you on Medfinder →

Is the Insulin Lispro shortage over in 2026?

The shortage has improved significantly but is not fully over. The 10 mL vials and KwikPen presentations have largely restabilized, but the 3 mL vials were permanently discontinued in October 2025. Some specific formulations and NDCs may still be intermittently unavailable depending on your region and pharmacy.

How much does Insulin Lispro cost without insurance in 2026?

Generic Insulin Lispro vials (10 mL) are available for as low as $25. Humalog brand vials cost approximately $100-$150 after Eli Lilly's 70% price cut. KwikPen 5-packs range from $175-$275 at retail, but discount coupons and the Lilly Insulin Value Program can reduce costs to $35/month or less.

Does Medicare cover Insulin Lispro?

Yes. Insulin Lispro is covered by most Medicare Part D plans. Under the Inflation Reduction Act, your copay for insulin under Medicare Part D is capped at $35 per month per insulin product, regardless of whether you use the brand-name or generic version.

Which Insulin Lispro products were discontinued?

Eli Lilly discontinued the 3 mL vial presentations of Insulin Lispro (NDC 0002-8213-05) in October 2025 as a business decision. The 10 mL vials, KwikPen prefilled pens (100 units/mL and 200 units/mL), Junior KwikPen, and Tempo Pen products continue to be manufactured.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy